- About
- Strategic Plan
- Structure
- Governance
- Scientific divisions
- ACRF Cancer Biology and Stem Cells
- ACRF Chemical Biology
- Advanced Technology and Biology
- Bioinformatics
- Blood Cells and Blood Cancer
- Clinical Translation
- Epigenetics and Development
- Immunology
- Infectious Diseases and Immune Defence
- Inflammation
- Personalised Oncology
- Population Health and Immunity
- Structural Biology
- Ubiquitin Signalling
- Laboratory operations
- Funding
- Annual reports
- Human research ethics
- Scientific integrity
- Institute life
- Career opportunities
- Business Development
- Business Development Office
- Partnering opportunities
- A complete cure for HBV
- A stable efficacious Toxoplasma vaccine
- Activating SMCHD1 to treat FSHD
- Improving vision outcomes in retinal detachment
- Intercepting inflammation with RIPK2 inhibitors
- Novel inhibitors for the treatment of lupus
- Novel malaria vaccine
- Novel mucolytics for the treatment of respiratory diseases
- Precision epigenetics silencing SMCHD1 to treat Prader Willi Syndrome
- Rethinking CD52 a therapy for autoimmune disease
- Targeting minor class splicing
- Partnerships and collaborations
- Royalties distribution
- Start-up companies
- Collaborators
- Publications repository
- Awards
- Discoveries
- Centenary 2015
- History
- Contact us
- Research
- Diseases
- Cancer
- Development and ageing
- Immune health and infection
- Research fields
- Research technologies
- People
- Anne-Laure Puaux
- Associate Profesor Ian Majewski
- Associate Professor Aaron Jex
- Associate Professor Alyssa Barry
- Associate Professor Andrew Webb
- Associate Professor Chris Tonkin
- Associate Professor Daniel Gray
- Associate Professor Diana Hansen
- Associate Professor Edwin Hawkins
- Associate Professor Emma Josefsson
- Associate Professor Ethan Goddard-Borger
- Associate Professor Grant Dewson
- Associate Professor Isabelle Lucet
- Associate Professor James Murphy
- Associate Professor James Vince
- Associate Professor Jason Tye-Din
- Associate Professor Jeanne Tie
- Associate Professor Jeff Babon
- Associate Professor Joan Heath
- Associate Professor Justin Boddey
- Associate Professor Kate Sutherland
- Associate Professor Leanne Robinson
- Associate Professor Marco Herold Marco Herold
- Associate Professor Marie-Liesse Asselin-Labat
- Associate Professor Matthew Ritchie
- Associate Professor Melissa Davis
- Associate Professor Misty Jenkins
- Associate Professor Nawaf Yassi
- Associate Professor Oliver Sieber
- Associate Professor Peter Czabotar
- Associate Professor Rachel Wong
- Associate Professor Rhys Allan
- Associate Professor Rosie Watson
- Associate Professor Ruth Kluck
- Associate Professor Sandra Nicholson
- Associate Professor Sant-Rayn Pasricha
- Associate Professor Seth Masters
- Associate Professor Sumitra Ananda
- Associate Professor Tim Thomas
- Associate Professor Wai-Hong Tham
- Associate Professor Wei Shi
- Catherine Parker
- Chela Niall
- Deborah Carr
- Dr Alisa Glukhova
- Dr Anna Coussens
- Dr Ashley Ng
- Dr Ben Tran
- Dr Bernhard Lechtenberg
- Dr Brad Sleebs
- Dr Drew Berry
- Dr Gemma Kelly
- Dr Gwo Yaw Ho
- Dr Hui-Li Wong
- Dr Jacqui Gulbis
- Dr Joanna Groom
- Dr John Wentworth
- Dr Kelly Rogers
- Dr Lucy Gately
- Dr Margaret Lee
- Dr Mary Ann Anderson
- Dr Maryam Rashidi
- Dr Matthew Call
- Dr Melissa Call
- Dr Philippe Bouillet
- Dr Rebecca Feltham
- Dr Rory Bowden
- Dr Samir Taoudi
- Dr Shabih Shakeel
- Dr Shalin Naik
- Dr Sheau Wen Lok
- Dr Simon Chatfield
- Dr Tracy Putoczki
- Guillaume Lessene
- Helene Martin
- Joh Kirby
- Kaye Wycherley
- Keely Bumsted O'Brien
- Mr Simon Monard
- Mr Steve Droste
- Ms Carolyn MacDonald
- Professor Alan Cowman
- Professor Andreas Strasser
- Professor Andrew Lew
- Professor Andrew Roberts
- Professor Anne Voss
- Professor Clare Scott
- Professor David Huang
- Professor David Komander
- Professor David Vaux
- Professor Doug Hilton
- Professor Gabrielle Belz
- Professor Geoff Lindeman
- Professor Gordon Smyth
- Professor Ian Wicks
- Professor Ivo Mueller
- Professor James McCarthy
- Professor Jane Visvader
- Professor Jerry Adams
- Professor John Silke
- Professor Ken Shortman
- Professor Leonard C Harrison
- Professor Lynn Corcoran
- Professor Marc Pellegrini
- Professor Marnie Blewitt
- Professor Melanie Bahlo
- Professor Mike Lawrence
- Professor Nicos Nicola
- Professor Peter Colman
- Professor Peter Gibbs
- Professor Phil Hodgkin
- Professor Stephen Nutt
- Professor Suzanne Cory
- Professor Terry Speed
- Professor Tony Burgess
- Professor Tony Papenfuss
- Professor Warren Alexander
- Diseases
- Education
- PhD
- Honours
- Masters
- Undergraduate
- Student research projects
- A new regulator of stemness to create dendritic cell factories for immunotherapy
- Advanced methods for genomic rearrangement detection
- Control of cytokine signaling by SOCS1
- Defining the protein modifications associated with respiratory disease
- Delineating the pathways driving cancer development and therapy resistance
- Developing a new drug that targets plasmacytoid dendritic cells for the treatment of lupus
- Development and mechanism of action of novel antimalarials
- Development of a novel particle-based malaria vaccine
- Development of tau-specific therapeutic and diagnostic antibodies
- Discovering novel therapies for major human pathogens
- Dissecting host cell invasion by the diarrhoeal pathogen Cryptosporidium
- Epigenetic biomarkers of tuberculosis infection
- Essential role of glycobiology in malaria parasites
- Evolution of haematopoiesis in vertebrates
- Human lung protective immunity to tuberculosis
- Identifying novel treatment options for ovarian carcinosarcoma
- Interaction with Toxoplasma parasites and the brain
- Interactions between tumour cells and their microenvironment in non-small cell lung cancer
- Investigating the role of mutant p53 in cancer
- Microbiome strain-level analysis using long read sequencing
- Minimising rheumatic adverse events of checkpoint inhibitor cancer therapy
- Modelling spatial and demographic heterogeneity of malaria transmission risk
- Naturally acquired immune response to malaria parasites
- Predicting the effect of non-coding structural variants in cancer
- Structural basis of catenin-independent Wnt signalling
- Structure and biology of proteins essential for Toxoplasma parasite invasion
- T lymphocytes: how memories are made
- TICKER: A cell history recorder for longitudinal patient monitoring
- Targeting host pathways to develop new broad-spectrum antiviral drugs
- Targeting post-translational modifications to disrupting the function of secreted proteins
- Targeting the epigenome to rewire pro-allergic T cells
- Targeting the immune microenvironment to treat KRAS-mutant adenocarcinoma
- The E3 ubiquitin ligase Parkin and mitophagy in Parkinson’s disease
- The molecular controls on dendritic cell development
- Understanding malaria infection dynamics
- Understanding the genetics of neutrophil maturation
- Understanding the neuroimmune regulation of innate immunity
- Understanding the proteins that regulate programmed cell death at the molecular level
- Using cutting-edge single cell tools to understand the origins of cancer
- When healthy cells turn bad: how immune responses can transition to lymphoma
- School resources
- Frequently asked questions
- Student profiles
- Abebe Fola
- Andrew Baldi
- Anna Gabrielyan
- Bridget Dorizzi
- Casey Ah-Cann
- Catia Pierotti
- Emma Nolan
- Huon Wong
- Jing Deng
- Joy Liu
- Kaiseal Sarson-Lawrence
- Komal Patel
- Lilly Backshell
- Megan Kent
- Naomi Jones
- Rebecca Delconte
- Roberto Bonelli
- Rune Larsen
- Runyu Mao
- Sarah Garner
- Simona Seizova
- Wayne Cawthorne
- Wil Lehmann
- Miles Horton
- Alexandra Gurzau
- Student achievements
- Student association
- News
- Donate
- Online donation
- Ways to support
- Support outcomes
- Supporter stories
- Rotarians against breast cancer
- A partnership to improve treatments for cancer patients
- 20 years of cancer research support from the Helpman family
- A generous gift from a cancer survivor
- A gift to support excellence in Australian medical research
- An enduring friendship
- Anonymous donor helps bridge the 'valley of death'
- Renewed support for HIV eradication project
- Searching for solutions to muscular dystrophy
- Supporting research into better treatments for colon cancer
- Taking a single cell focus with the DROP-seq
- WEHI.TV
Bright ideas among $31M Australian Government funding boost
16 December 2020
WEHI’s COVID-19, dementia and blood cancer researchers are among the beneficiaries of $10.9M of National Health and Medical Research Council (NHMRC) funding announced this week by the Australian Government.
The new NHMRC Ideas Grants and Postgraduate Scholarships are part of a total of $31.5M of NHMRC funding grants received by WEHI’s researchers in 2020. This has included:
- Twelve NHMRC Ideas Grants, supporting teams of researchers
- Two NHMRC Postgraduate Scholarships, enabling our successful clinician-researchers to undertake training via a higher degree by research
- Ten NHMRC Investigator Grants contributing to the research program of individual researchers
- One NHMRC e-ASIA Joint Research Program Grant, supporting an international collaboration to investigate dengue fever
At a glance
- The Australian Government’s NHMRC has announced WEHI researchers have received 12 Ideas Grants and two Postgraduate Scholarships in 2020 funding round.
- The funding will support WEHI researchers’ work to improve the understanding, diagnosis and treatment of a range of diseases, including COVID-19, dementia and blood cancers.
Better antiviral therapies
towards new antiviral medicines received an NHMRC
Ideas Grant
Associate Professor Ethan Goddard-Borger received an NHMRC Ideas Grant for his research towards developing new antiviral medicines which could help to treat COVID-19 as well as other globally significant and emerging viruses. The research builds on Associate Professor Goddard-Borger’s long-term interest in how proteins are modified by sugars – a field called glycobiology – and will use the drug discovery capabilities of WEHI’s National Drug Discovery Centre.
“The COVID-19 pandemic has exposed the dearth of effective broad-spectrum anti-viral medicines in our current pharmacopeia,” he said. “This project will focus on developing drug candidates that target specific human proteins that are required by viruses to replicate within our cells. By targeting common human components required for infection, rather than the virus itself, we hope to develop new medicines that could be effective against a wide range of viruses – including SARS-CoV-2 and those viruses which may emerge in the future. This will avoid the long lead time required to develop a medicine that is specific to a particular virus.
“This research builds on fundamental cell biology and drug discoveries made since the 1980s. Our access to WEHI’s leading drug discovery capabilities and virus research facilities means we can take a fresh look at this promising approach to antiviral drug development. We hope that this research will lead to new and enduring tools for combating current and future viral threats,” Associate Professor Goddard-Borger said.
Improving how dementia is diagnosed
will enable her to investigate dementia.
An NHMRC Postgraduate Research Fellowship was awarded to Dr Paula Loveland, a clinician specialising in geriatric medicine. Dr Loveland said the funding would enable her to undertake PhD studies with Associate Professor Rosie Watson and Associate Professor Nawaf Yassi, which will focus on improving the diagnosis of people with dementia.
“Lewy body dementia is a common yet under-recognised form of dementia in older people,” she said. “Improving how the condition is diagnosed would greatly improve outcomes for patients and their families – and my research is focussed on whether this could be achieved using a blood test.”
“My PhD studies will be part of the Lewy Body Study, a Melbourne-based longitudinal clinical and biomarker study of Lewy body dementia. We will look for markers of neurodegeneration and inflammation in the blood of people with dementia, to see whether they correlate with changes in the brain seen by neuroimaging, as well as clinical outcomes. This could lead to more rapid and accurate ways to diagnose people with Lewy body dementia, allowing these people to receive the best therapies for their condition. We also hope these biomarkers may indicate how Lewy body dementia develops, potentially leading to the discovery of new therapies,” Dr Loveland said.
Overcoming a common driver of blood cancers
to support her research into blood cancers
Dr Gemma Kelly received two NHMRC Ideas Grants, which will support her team’s research into blood cancers that have faults in a tumour suppressor protein called p53. She said it was exciting to have ongoing funding support to advance her research for the next three years.
“A large number of cancer cells contain faults in p53, and as well as driving cancer this can also contribute to cancers’ resistance to common therapies,” she said. “Our research will investigate at the molecular level how p53 normally protects cells from cancer-causing changes, as well as how faults in p53 can make cells resistant to a broad range of cancer therapies.
“Despite intense worldwide efforts, restoring p53’s function in cancer cells has not been possible. Our research instead will look for the ‘partners in crime’ of faulty p53, potentially identifying new targets that could be used to treat blood cancers,” she said.
Dr Kelly’s Ideas Grants support a team of researchers including experts in bioinformatics, molecular biology, immunology and clinical studies. “While we are tackling some of the most-asked questions in cancer biology, by bringing together a team of people with diverse expertise we can take new approaches to solving these problems – and bring us closer to life-saving new therapies for people with blood cancer.”
Critical support
NHMRC funding is a critical component of Australia’s medical research sector, said WEHI director Professor Doug Hilton AO. “For 92 years, the Australian Government has supported outstanding medical research that has improved the health and wellbeing of Australians. This year’s NHMRC grants have gone to remarkable researchers at all stages of the career path, and I will watch the progress of their research with excitement.
“I’d also like to acknowledge the valuable support many of these researchers have received in the leadup to their funding, in particular from philanthropists who have been able to step in to support outstanding researchers who have just missed out on government funding. This synergy is critical in ensuring scientists, at all stages of their career, are able to progress their research, make new discoveries and translate these into improvements in disease prevention diagnosis and treatment."
Media inquiries
M: +61 475 751 811
E: communityrelations@wehi.edu.au
Super Content:
Want to hear about our latest discoveries? Subscribe to our supporter newsletter, Illuminate.
The institute promotes a scientific environment that emphasises innovation, collaboration and excellence.
Explore the current opportunities to join our team.
Our researchers are working towards better approaches to diagnose, treat and prevent the spread of coronaviruses, both to address the current COVID-19 global outbreak as well as in preparedness for likely future coronaviral disease outbreaks.
Our scientists are working to improve the detection of neurodegenerative conditions that cause dementia.
The NDDC enables medical researchers to access ultra-high throughput screening, fast tracking scientific discoveries into new medicines.